Kiwa Bio-Tech Products Group Corp (fka KWBT)

[operating_line]

Exactly, agree with all.

100 million market cap could be realistic if financials next month confirms the expected sales. There was that earlier report suggesting 160 million.

https://seekingalpha.com/instablog/21922151-bioresearch-alert/5452232-two-cent-kwbt-ready-to-soar

Rong family were quite impressed at CAF 2018. Lets see if they follow through with anything. We had interest in Q2 from the a China state owned company via a first order of $7.5 million. This relationship can bear more fruit for KWBT so that is another possibility. Recent news of Bayer and Syngenta making acquisitions in the ag biotech space confirms the sector is heating up and these companies visit CAF.

Even if sales were to fall from expected 48 million to 30 million, PPS should reflect a market cap much higher than currently. If revenues can keep coming in to clean up the balance sheet, I hope they can show a solid agreement for discounting commercial notes with sufficient safety margin to avoid a squeeze again.

Lets hope Kiwa Biotech attends CAF again. Their HQ in Yangling is in well located for this.